Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 71

1.

Comparison between Xingnaojing Injection () and Naloxone in Treatment of Acute Alcohol Intoxication: An Updated Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Cao HJ, Cheng N, Wang RT, Huang XY, Wu JR.

Chin J Integr Med. 2019 Aug 5. doi: 10.1007/s11655-019-3037-3. [Epub ahead of print]

PMID:
31388972
2.

Role of Xingnaojing combined with naloxone in treating intracerebral haemorrhage: A systematic review and meta-analysis of randomized controlled trials.

Xu YM, Wang XC, Zhang SJ, Xu TT, Li HY, Hei SY, Wen ZH, Ma YZ, Wang Q, Liang WX.

Medicine (Baltimore). 2018 Oct;97(43):e12967. doi: 10.1097/MD.0000000000012967. Review.

3.

Meta-Analysis for Clinical Evaluation of Xingnaojing Injection for the Treatment of Cerebral Infarction.

Ma X, Yang YX, Chen N, Xie Q, Wang T, He X, Wang J.

Front Pharmacol. 2017 Aug 29;8:485. doi: 10.3389/fphar.2017.00485. eCollection 2017. Review.

4.

Evaluation of the adjunctive effect of Xing Nao Jing Injection for viral encephalitis: A systematic review and meta-analysis of randomized controlled trials.

Cao HJ, Liang SB, Zhou W, Wu JR, Zhang CL.

Medicine (Baltimore). 2019 Apr;98(15):e15181. doi: 10.1097/MD.0000000000015181.

5.

Meta-Analysis of the Effects of Xingnaojing Injection on Consciousness Disturbance.

Wu L, Zhang H, Xing Y, Gao Y, Li Y, Ren X, Li J, Nie B, Zhu L, Shang H, Gao Y.

Medicine (Baltimore). 2016 Feb;95(7):e2875. doi: 10.1097/MD.0000000000002875. Review.

6.

Efficacy and safety of Xuebijing injection (a Chinese patent) for sepsis: A meta-analysis of randomized controlled trials.

Li C, Wang P, Zhang L, Li M, Lei X, Liu S, Feng Z, Yao Y, Chang B, Liu B, Shang H.

J Ethnopharmacol. 2018 Oct 5;224:512-521. doi: 10.1016/j.jep.2018.05.043. Epub 2018 Jun 1. Review.

PMID:
29860133
7.

Systematic review and meta-analysis of randomized controlled trials of xingnaojing treatment for stroke.

Peng W, Yang J, Wang Y, Wang W, Xu J, Wang L, Xing Z.

Evid Based Complement Alternat Med. 2014;2014:210851. doi: 10.1155/2014/210851. Epub 2014 Feb 24. Review.

8.

Oral hygiene care for critically ill patients to prevent ventilator-associated pneumonia.

Hua F, Xie H, Worthington HV, Furness S, Zhang Q, Li C.

Cochrane Database Syst Rev. 2016 Oct 25;10:CD008367. Review.

9.

Mu-opioid antagonists for opioid-induced bowel dysfunction in people with cancer and people receiving palliative care.

Candy B, Jones L, Vickerstaff V, Larkin PJ, Stone P.

Cochrane Database Syst Rev. 2018 Jun 5;6:CD006332. doi: 10.1002/14651858.CD006332.pub3. Review.

10.

Chinese herbal medicine for oesophageal cancer.

Chen X, Deng L, Jiang X, Wu T.

Cochrane Database Syst Rev. 2016 Jan 22;(1):CD004520. doi: 10.1002/14651858.CD004520.pub7. Review.

PMID:
26799001
11.

Aloe vera for prevention and treatment of infusion phlebitis.

Zheng GH, Yang L, Chen HY, Chu JF, Mei L.

Cochrane Database Syst Rev. 2014 Jun 4;(6):CD009162. doi: 10.1002/14651858.CD009162.pub2. Review.

12.

Oral H1 antihistamines as 'add-on' therapy to topical treatment for eczema.

Matterne U, Böhmer MM, Weisshaar E, Jupiter A, Carter B, Apfelbacher CJ.

Cochrane Database Syst Rev. 2019 Jan 22;1:CD012167. doi: 10.1002/14651858.CD012167.pub2.

PMID:
30666626
13.

Pharmacotherapy for anxiety and comorbid alcohol use disorders.

Ipser JC, Wilson D, Akindipe TO, Sager C, Stein DJ.

Cochrane Database Syst Rev. 2015 Jan 20;1:CD007505. doi: 10.1002/14651858.CD007505.pub2. Review.

PMID:
25601826
14.

Marine-derived n-3 fatty acids therapy for stroke.

Alvarez Campano CG, Macleod MJ, Aucott L, Thies F.

Cochrane Database Syst Rev. 2019 Jun 26;6:CD012815. doi: 10.1002/14651858.CD012815.pub2. Review.

PMID:
31242320
15.

Chinese herbal medicine for menopausal symptoms.

Zhu X, Liew Y, Liu ZL.

Cochrane Database Syst Rev. 2016 Mar 15;3:CD009023. doi: 10.1002/14651858.CD009023.pub2. Review.

16.

Herbal medicines for viral myocarditis.

Liu ZL, Liu ZJ, Liu JP, Kwong JS.

Cochrane Database Syst Rev. 2013 Aug 28;(8):CD003711. doi: 10.1002/14651858.CD003711.pub5. Review. Update in: Cochrane Database Syst Rev. 2016;(5):CD003711.

PMID:
23986406
17.

Cochrane Review: Osmotic and stimulant laxatives for the management of childhood constipation (Review).

Gordon M, Naidoo K, Akobeng AK, Thomas AG.

Evid Based Child Health. 2013 Jan;8(1):57-109. doi: 10.1002/ebch.1893. Review.

PMID:
23878124
18.

Early enteral nutrition within 24 hours of lower gastrointestinal surgery versus later commencement for length of hospital stay and postoperative complications.

Herbert G, Perry R, Andersen HK, Atkinson C, Penfold C, Lewis SJ, Ness AR, Thomas S.

Cochrane Database Syst Rev. 2018 Oct 24;10:CD004080. doi: 10.1002/14651858.CD004080.pub3. Update in: Cochrane Database Syst Rev. 2019 Jul 22;7:CD004080.

PMID:
30353940
19.

Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD).

Storebø OJ, Ramstad E, Krogh HB, Nilausen TD, Skoog M, Holmskov M, Rosendal S, Groth C, Magnusson FL, Moreira-Maia CR, Gillies D, Buch Rasmussen K, Gauci D, Zwi M, Kirubakaran R, Forsbøl B, Simonsen E, Gluud C.

Cochrane Database Syst Rev. 2015 Nov 25;(11):CD009885. doi: 10.1002/14651858.CD009885.pub2. Review.

PMID:
26599576
20.

TNF-alpha inhibitors for ankylosing spondylitis.

Maxwell LJ, Zochling J, Boonen A, Singh JA, Veras MM, Tanjong Ghogomu E, Benkhalti Jandu M, Tugwell P, Wells GA.

Cochrane Database Syst Rev. 2015 Apr 18;(4):CD005468. doi: 10.1002/14651858.CD005468.pub2. Review.

PMID:
25887212

Supplemental Content

Support Center